Business · 10/08/2020
FDA Releases Draft Guidance for Industry on Drug-Drug Interaction Assessment for Therapeutic Proteins
The Food and Drug Administration (FDA) has released a draft guidance for industry titled "Drug-Drug Interaction Assessment for Therapeutic Proteins," which aims to help pharmaceutical companies assess the potential for drug interactions with therapeutic proteins.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →